Price Alert

Trinity Biotech (TRIB)

NASDAQ: TRIB · Real-Time Price · USD

1.63

-0.28 (-14.66%)

At close: Aug 15, 2025, 3:59 PM

1.48

-9.20%

After-hours: Aug 15, 2025, 07:58 PM EDT

Trinity Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	5.17M	2.84M	5.32M	5.78M	3.69M	-12.52M	-13.19M	-13.59M	6.58M	7.25M	10.45M	10.01M	25.91M	27.48M	28.62M	32.28M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	18.78M	27.42M	17.12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	2.46M	190K	193K	232K	214K	196K	214K	1.5M	212K	147K	140K	219K	151K	n/a	n/a	n/a
Other Long-Term Assets	194K	233K	79K	79K	43K	98K	108K	272K	55K	155K	207K	175K	56K	244K	279K	315K
Receivables	14.6M	21.43M	17.71M	17.62M	13.38M	16.69M	16.11M	15.45M	13.45M	19.03M	17.68M	18.63M	15.71M	18.66M	18.14M	17.75M
Inventory	19.37M	21.8M	22.96M	22.64M	19.93M	20.88M	22.58M	21.53M	22.5M	23.55M	29.11M	29.63M	29.12M	32.12M	34.7M	37.58M
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	17.75M	2.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	41.12M	46.08M	45.98M	46.04M	39.04M	43.83M	52.92M	58.26M	46.67M	49.83M	57.24M	58.27M	72.69M	78.25M	81.46M	87.61M
Property-Plant & Equipment	4.62M	3.77M	3.91M	3.36M	1.89M	1.8M	1.87M	5.5M	5.68M	6.08M	6.26M	5.63M	5.92M	6.26M	6.5M	8.65M
Goodwill & Intangibles	51.34M	46.67M	41.79M	38.57M	16.27M	16.16M	15.76M	21.33M	35.27M	37.14M	38.74M	37.32M	35.98M	34.32M	32.86M	35.2M
Total Long-Term Assets	62.17M	51.37M	48.37M	44.27M	20.39M	19.77M	19.07M	32.9M	45.44M	48.06M	49.9M	47.83M	46.21M	44.53M	43.26M	48.37M
Total Assets	103.29M	97.45M	94.36M	90.31M	59.44M	63.6M	71.99M	91.16M	92.1M	97.89M	107.14M	106.1M	118.89M	122.78M	124.72M	135.98M
Account Payables	6.83M	25.31M	23.07M	20.53M	3.88M	10.63M	12.57M	12.91M	6.21M	14.45M	11.78M	15.64M	6.76M	18.32M	21.3M	30.88M
Deferred Revenue	197K	n/a	283K	337K	50K	n/a	n/a	83K	114K	n/a	n/a	n/a	141K	n/a	n/a	n/a
Short-Term Debt	210K	210K	210K	210K	210K	210K	210K	210K	210K	210K	210K	210K	83.34M	83.16M	83.19M	n/a
Other Current Liabilities	2.57M	50K	50K	50K	1.18M	302K	337K	1.39M	153K	71K	71K	90K	282K	1.39M	1.13M	765K
Total Current Liabilities	32.09M	28.05M	25.77M	22.82M	15.04M	12.74M	14.76M	16.15M	17.34M	14.73M	13.88M	15.94M	100.49M	102.88M	105.62M	31.65M
Long-Term Debt	87.79M	81.62M	80.77M	73.42M	54.65M	54.28M	53.93M	63.13M	58.05M	57.7M	57.36M	76.25M	n/a	n/a	n/a	84.05M
Other Long-Term Liabilities	3.55M	2.39M	3.23M	3.13M	526K	1.14M	1.53M	1.52M	1.57M	1.68M	14.72M	1.67M	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	106.38M	95.73M	97.98M	90.34M	68.35M	68.35M	68.61M	81.63M	76.94M	76.53M	77.44M	96.44M	18.72M	19.09M	19.6M	104.46M
Total Liabilities	138.47M	123.79M	123.75M	113.16M	83.38M	81.08M	83.37M	97.78M	94.28M	91.26M	91.32M	112.38M	119.21M	121.97M	125.22M	136.11M
Total Debt	100.76M	93.72M	93.33M	85.64M	67.43M	67.02M	67.33M	76.93M	58.26M	57.91M	59.39M	76.46M	99.16M	83.16M	83.19M	84.05M
Common Stock	4.19M	2.38M	2.34M	2.34M	1.97M	1.97M	1.97M	1.97M	1.96M	1.96M	1.96M	1.45M	1.21M	1.21M	1.21M	1.21M
Retained Earnings	-79.12M	-62.3M	-57.79M	-51.15M	-48.64M	-42.13M	-36.15M	-31.14M	-26.7M	-17.93M	-9.1M	481K	12.56M	13.69M	12.09M	12.56M
Comprehensive Income	-5.44M	-5.72M	1.03M	928K	1.03M	-5.73M	-5.61M	-5.76M	-5.69M	-5.78M	-5.42M	-5.16M	-5.36M	-5.35M	-5.07M	-5.17M
Shareholders Equity	-35.18M	-26.34M	-29.4M	-22.86M	-23.95M	-17.49M	-11.38M	-6.62M	-2.18M	6.63M	15.82M	-6.29M	-319K	810K	-496K	-127K
Total Investments	2.46M	190K	193K	232K	214K	18.98M	27.63M	1.5M	212K	147K	140K	219K	151K	n/a	n/a	n/a